Dan Gustafson

Antitumor Activity of the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Gefitinib (ZD1839, Iressa) in Non–Small Cell Lung Cancer Cell Lines Correlates with Gene Copy Number and EGFR Mutations but not EGFR Protein Levels

Barbara A. Helfrich, David Raben, Marileila Varella‐Garcia et al. · Clinical Cancer Research · 2006 · 124 citations · Full text

Medicine, Oncology, Pharmacology +17

ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinase activity in combination with radiotherapy

Barbara Frederick, Dan Gustafson, Cataldo Bianco et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 34 citations

Medicine, Oncology, Pharmacology +11

Vertical Distribution of Epiphytic Lichens on Three Tree Species in Yellowstone National Park

Sharon Eversman, Carol Barnes Johnson, Dan Gustafson · The Bryologist · 1987 · 30 citations

Life Sciences, Botany, Plant Sciences +16

A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumors

Lia Gore, S. Holden, R.B. Cohen et al. · Annals of Oncology · 2006 · 18 citations · Full text

Medicine, Oncology, Pharmacology +11

Phase I and pharmacokinetic study of docetaxel combined with melphalan and carboplatin, with autologous hematopoietic progenitor cell support, in patients with advanced refractory malignancies

Yago Nieto, Elizabeth J. Shpall, Scott I. Bearman et al. · Biology of Blood and Marrow Transplantation · 2005 · 11 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +17